ERBB4 Antilichaam

This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized.

2066

Q15303

Rat

A synthetic peptide corresponding to a sequence within amino acids 1150-1250 of human ERBB4 (NP_005226.1) .

Unconjugated

Primary Antibodies

Cancer, Cell Cycle, Growth Factors, Immunology, Signal Transduction

Affinity purification

Rat brain

Batch dependent

PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

None

Blue Ice

Store at -20˚ C. Avoid freeze / thaw cycles.

Observed: 147kDa

IgG

WB: 1:500 - 1:2000

ERBB4

V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4

Homo sapiens

ERBB4, ERBB 4, HER4, p180 erb4, p180erbB4

WB

Liquid